Remove 2019 Remove Diabetes Remove Immunity
article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

November 21, 2019. Effect of acalabrutinib in combination with bendamustine plus rituximab on survival endpoints in older patients with mantle cell lymphoma: insights from the ECHO trial. healthbook TIMES Onco Hema. 2024;22(4):22-29. doi:10.36000/HBT.OH.2024.22.163 ClinicalTrials.gov. Updated February 19, 2025. Accessed May 14, 2025.

article thumbnail

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Pharmacy Times

4 Novak added that these services align well with appointment-based models and can be layered with immunizations, chronic disease monitoring, and medication therapy management. May 9, 2019. Addressing Barriers and Finding Solutions Despite the promise of these services, challenges remain. Presented at: McKesson ideaShare 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

Pharmacy Times

million deaths in 2019 alone. This post hoc secondary analysis, published by investigators in JAMA Network , aims to determine if this intervention had a spillover effect on antibiotic prescribing across the entire patient population. 1 Image credit: I Viewfinder | stock.adobe.com According to WHO, AMR accounted for 1.27

article thumbnail

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Pharmacy Times

1,2 Tafamidis in the Treatment of ATTR-CM Initially approved in 2019 3 , tafamidis (Vyndamax; Pfizer) is a selective transthyretin (TTR) kinetic stabilizer that binds to thyroxine-binding sites on TTR tetramers, which prevents dissociation into monomers, or the breakdown into amyloid deposits that damage the heart in ATTR-CM. May 6, 2019.

article thumbnail

Because Ned Said: New Technology Helps Prevent Opioid Overdose

Pharmacy Times

September 9, 2019. trillion economic impact in 2020. May 21, 2025. Accessed May 27, 2025. Acura Pharmaceuticals engages Catalent Pharma Solutions to advance development of LTX-03. News release. FirstWord Pharma. Accessed May 27, 2025. Acura Pharmaceuticals, Inc. US Securities and Exchange Commission; 2025. Accessed May 27, 2025.

article thumbnail

Zanubrutinib Linked to Lower Infection Risk Than Venetoclax Plus Obinutuzumab in Real-World CLL/SLL Study

Pharmacy Times

However, patients with CLL/SLL typically have a higher risk of serious infection due to their compromised immune systems, raising concerns about the association between CLL/SLL-directed therapies and serious infection risks.

article thumbnail

Does Corticosteroid Use Have a Role in Severe Community-Acquired Pneumonia?

Pharmacy Times

Community-acquired pneumonia (CAP) is a common infection caused by the inhalation of various organisms into the lower respiratory tract, which can ultimately initiate an immune and inflammatory response, potentially leading to damage to lung parenchyma. This timeline was chosen based on the publication of the 2019 ATS/IDSA guidelines.